Navigation Links
Largest ever Alzheimer's genome study unveils dementia mysteries
Date:9/6/2009

related to memory performance in Alzheimer's disease, thus changes in genes which affect synapses are likely to have a direct effect on disease development."

"This research is changing our understanding of what causes the common form of Alzheimer's disease and provides valuable new leads in the race to find treatments and possibly cures."

"It also shows that other genes can be identified using this method, and the group are already planning a larger study involving 60,000 people, which can be achieved within the next year."

Rebecca Wood, Chief Executive of the Alzheimer's Research Trust, which part-funded the study, said: "These findings are a leap forward for dementia research. At a time when we are yet to find ways of halting this devastating condition, this development is likely to spark off numerous new ideas, collaborations and more in the race for a cure.

"The work of Professor Williams and colleagues shows how British researchers lead the world in the struggle to understand and defeat dementia. With the right support for scientists, we can offer hope to the 30 million people worldwide who live with dementia.

The First Minister for Wales, Rhodri Morgan, said: "This major breakthrough in the battle to understand and develop treatments for Alzheimer's is good news for the 37,000 people in Wales and their carers who are affected by Alzheimer's or other forms of dementia. It is a real feather in the cap of Welsh science that this important global study has been led by a Welsh scientist, Professor Julie Williams and that the Welsh Assembly Government was able to give financial support for her work. World-class research like this will help lead to improved treatment for this distressing disease, and may one day even mean we can cure dementia."

Sir Leszek Borysiewicz, Chief Executive of the Medical Research Council, said: "Funding work on neurodegenerative diseases is a priority for us and MRC investment in thi
'/>"/>

Contact: Andrew Scheuber
ascheuber@alzheimers-research.org.uk
44-774-827-2171
Alzheimer's Research Trust
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. Worlds largest ocean observatory takes shape
2. One of the Largest Wendys(R) Franchisees, Tar Heel Capital, Reduces Fraud and Slashes Costs with DigitalPersona
3. Scientists identify worlds largest leatherback turtle population
4. Disappearing act of worlds second largest fish explained
5. DOE makes largest Danforth Campus research award in history
6. Worlds largest snake discovered in fossilized rainforest
7. Largest prehistoric snake on record discovered in Colombia
8. At 2,500 pounds and 43 feet, prehistoric snake is the largest on record
9. Tips for making a green holiday from the worlds largest scientific society
10. Less than one month to opening of world’s largest global congress on osteoporosis
11. Paradigm Tactical Products to be Largest Distributor of Metal/Radiation Detection Wands in United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2010)... may eventually emerge as a lymphoma treatment, according to ... International Conference on Advances in Cancer Research: From the ... , Lymphoma is a cancer of the immune system ... are then further classified into B-cell and T-cell groups. ... resistant to standard treatment and thus new therapies are ...
(Date:3/10/2010)... Ala. Discovery of an antibiotic,s capacity to ... movement disorder researchers with leads to more desirable ... of Alabama scientists co-authoring a paper publishing March ... Mechanisms ., "It,s our hope that this ... clinical trial to evaluate the potential of drugs ...
(Date:3/10/2010)... Scientists have gained new insight into why a relatively ... hearing deficits, long after hearing is restored to normal. ... 11 issue of the journal Neuron , reveals ... auditory cortex is quite vulnerable if it does not ... , It is well established that degraded sensory experience ...
Breaking Biology News(10 mins):Movement disorder symptoms are lessened by an antibiotic 2Movement disorder symptoms are lessened by an antibiotic 3Research reveals that temporary hearing deprivation can lead to 'lazy ear' 2Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 1Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 1ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 3ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 4Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 1Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 2
... major cause of hospital-acquired infections can persist for ... in healthcare settings, including bed linens, computer keyboard ... today at the 105th General Meeting of the ... (MRSA) is a major cause of hospital-acquired infections ...
... of two critical proteins that normally shut down during ... the Cold Spring Harbor Laboratory have cured fruit flies ... same proteins-known in short form as CREB and HSP-70--exist ... study results, published online today by the Proceedings of ...
... University of Pittsburgh researchers first to report function of ... each other by an extensive network of tiny tunnels ... used to shoot signals to distant cells. This surprising ... of Medicine researchers in the September issue of the ...
Other Biology News:Huntington's cure in flies lays groundwork for broader treatment approaches 2'Underground' tunnels discovered as means for communication between immune system cells 2'Underground' tunnels discovered as means for communication between immune system cells 3'Underground' tunnels discovered as means for communication between immune system cells 4
(Date:3/11/2010)... at Philadelphia Conference , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced it will ... Bank and Cowen & Company at CBI,s 2010 Accounting and ... attended each year by over 300 finance, accounting, audit and ...
(Date:3/10/2010)... March 11 Thomson Reuters today announced it has ... Times Higher Education,s influential World University Rankings. The survey reflects ... resource to the global scholarly community. , ... ... ...
(Date:3/10/2010)... today announced the appointment of Mr. Kevin Giese , President, CEO and Director of BioMS Medical and Mr. Laine Woollard, QC , Senior Legal ... ... , ... ... ...
(Date:3/10/2010)... , ... ... ... , ... ...
Breaking Biology Technology:ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3Spectral appoints two new board members 2Spectral appoints two new board members 3BR Ventures Invests in Semprae Laboratories 2BR Ventures Invests in Semprae Laboratories 3BR Ventures Invests in Semprae Laboratories 4
... Inc.,(Nasdaq: ONTY ) (TSX: ONY) (the "Company") ... in a Phase 1b clinical trial of PX-12 ... proprietary small molecule,inhibitor of thioredoxin, a protein that ... survival and drug resistance of,many cancers., The ...
... lecture and present a poster on proprietary siRNA ... targeting ... Quark Pharmaceuticals, Inc., a,development-stage pharmaceutical company discovering and developing ... the Cambridge Healthcare Institute,s 9th Annual Beyond,Genome Conference on ...
... DURECT Corporation,(Nasdaq: DRRX ) announced today that ... has been submitted to the U.S. Food,and Drug ... long,acting oral formulation of oxycodone intended to treat ... Remoxy is designed to resist,common methods of prescription ...
Other Biology Technology:Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 2Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 3Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 2Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5